Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

9.320 +0.850 (+10.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
60 61 Next >
What's Going On With Novavax (NVAX) Stock
Novavax Inc (NASDAQ: NVAX) shares are trading higher by 4.34% to $8.06 Thursday afternoon. The company rescheduled its 2023 Annual Meeting of Stockholders from June 15 to July 11 at 8:30 a.m. ET. 
Via Benzinga
7 High-Risk, High-Reward Stocks to Buy in June
These are the best high-risk, high-reward stocks to buy in June. They can all generate big profits for investors. 
Via InvestorPlace
1 Stock Down 83% That Could Triple, According to Wall Street
It would be quite the turnaround for the vaccine maker. 
Via The Motley Fool
3 Penny Stocks That Could Skyrocket in the Next 12 Months
Find the top penny stocks to buy, and you can make a fortune. Pick the wrong one and there are also plenty of horrors. 
Via InvestorPlace
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Looking Into Novavax's Return On Capital Employed
Via Benzinga
Thinking of Buying Novavax Stock? 3 Numbers You Should Look at First
Has the vaccine-focused biotech become a safer investment? 
Via The Motley Fool
Up 40% in 1 Day, Is Novavax Stock a Buy Now?
The market is being a bit too exuberant about the struggling biotech's latest earnings report. 
Via The Motley Fool
SEC Accuses Binance & Coinbase Of Acting As Unregistered Broker, Binance Takes Biggest Hit As $300M In Crypto Positions Liquidated In 24 Hours, JPMorgan Clarifies CEO Jamie Dimon Not Running For Presidency: Today's Top Stories
Benzinga 
Via Benzinga
Novavax's New Vaccine Approach Set to Tackle Rising COVID-19 Emerging Variants
Novavax Inc's (NASDAQ: NVAX) R&D chief Filip Dubovsky expressed confidence that the company's updated COVID-19 vaccine, already in production, will offer protection against the rapidly emerging... 
Via Benzinga
3 Biotech Stocks to Sell in June Before They Crash and Burn
Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them. 
Via InvestorPlace
7 F-Rated Stocks to Sell in June
As summer arrives, this is a good time for a quick portfolio evaluation and weed out those names that are most likely to underperform. 
Via InvestorPlace
Is the Worst Over for Novavax?
Novavax shares climbed 26% in one trading session on the latest cost-cutting news. 
Via The Motley Fool
Do You Really Want AI To Pick Your Stocks?
AI this and AI that. It seems AI is dominating a huge part of our national discussion. 
Via Talk Markets
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
These companies haven't given up on the coronavirus vaccine market. 
Via The Motley Fool
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction
(Wednesday market open) Investors seeking distraction from the ticking debt ceiling countdown clock get some this afternoon in the form of Federal Reserve meeting minutes and Nvidia (NASDAQ: NVDA)... 
Via Benzinga
Why Novavax, Pfizer And BioNTech Shares Are Rising Today
Shares of vaccine makers Novavax Inc (NASDAQ: NVAX), Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) a 
Via Benzinga
The 3 Best Stocks to Short in May 2023
The best stocks to short are companies whose businesses aren’t faring well and have a higher-than-average short interest. 
Via InvestorPlace
Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
Wall Street Expects These Unique Stocks to Skyrocket 314% to 943%
Select analysts believe three former high-flying stocks can make their shareholders significantly richer. 
Via The Motley Fool
Is Novavax Finally Turning Things Around?
Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious disea 
Via MarketBeat
Exposures COVID-19
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Is the biotech on the road to recovery? 
Via The Motley Fool
Short-Squeeze Stocks Alert: CVNA, NVAX Make Most-Shorted Stocks List
Business news outlet CNBC recently posted its list of top short-squeeze stocks, which present potentially lucrative though risky ideas. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Tempur Sealy International To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday
Keybanc raised the price target for Tempur Sealy International, Inc. (NYSE: TPX) from $48 to $50. Keybanc analyst Bradley Thomas maintained an Overweight rating. Tempur Sealy International shares rose... 
Via Benzinga
S&P Settles Lower Ahead Of CPI; Market Volatility Increases
The S&P 500 closed lower on Tuesday ahead of consumer price index report. 
Via Benzinga
Gold Edges Higher; PayPal Shares Tumble Despite Upbeat Earnings
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Tuesday. The Dow traded down 0.01% to 33,616.00 while the NASDAQ fell 0.43% to... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
VIX Rallies Amid Quiet Day On Wall Street
Wall Street is relatively quiet today, as investors continue to await this week's inflation data. 
Via Talk Markets
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
60 61 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.